RNA, U6 small nuclear 914, pseudogene (RNU6-914P)

RNA, U6 small nuclear 914, pseudogene (RNU6-914P) is classified as a human pseudogene derived from the highly conserved U6 small nuclear RNA (snRNA) gene family. U6 snRNA itself is a core component of the spliceosome, the complex responsible for removing introns during pre-mRNA splicing, and is highly conserved and essential in eukaryotes[1][3]. However, RNU6-914P is a pseudogene—defined as a genomic sequence similar to a known gene but generally non-functional due to accumulated mutations that prevent it from producing functional RNA or protein products[2][3]. Pseudogenes like RNU6-914P may be transcribed and can, in rare cases, participate in regulatory roles such as functioning as competing endogenous RNAs (ceRNAs) or generating small regulatory RNAs, but most generally lack intrinsic biological activity and are not considered direct therapeutic targets[2]. RNU6-914P is not known to encode a receptor, enzyme, transporter, or other canonical drug target class, and it has no established direct relevance to disease biology, drug interaction, or biomarker status. Its presence reflects the prevalence of U6 snRNA gene duplications and backups in vertebrate genomes, underlining the evolutionary importance of this gene family[3]. In summary, RNU6-914P is not a druggable target, is not a receptor or enzyme, and has no clear associated disease or therapeutic significance. Its designation as a pseudogene means it is generally considered non-functional and is not a biological target for intervention[2][3].

Other names

RNU6-914PRNA, U6 small nuclear 914, pseudogene